The effect of the aqueous extract of the roots of Asparagus racemosus on hepatocarcinogenesis initiated by diethylnitrosamine

被引:26
作者
Agrawal, Alka [1 ]
Sharma, Meenakshi [1 ]
Rai, Santosh Kumar [1 ]
Singh, Bharat [2 ]
Tiwari, Manisha [1 ]
Chandra, Ramesh [1 ]
机构
[1] Univ Delhi, Dr BR Ambedkar Ctr Biomed Res, Delhi 110007, India
[2] Univ Coll Med Sci, Dept Pathol, Delhi 110095, India
关键词
hepatocarcinogenesis; Asparagus racemosus; p53; diethylnitrosamine; histopathology;
D O I
10.1002/ptr.2391
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Histopathological studies of the hepatic tissues of Wistar rats treated with diethylnitrosamine (DEN) (200 mg/kg b wt, i.p.) once a week for 2 weeks, followed by treatment with DDT, a tumor promoter (0.05% in diet) for 2 weeks and kept under observation for another 18 weeks, demonstrated the development of malignancy. Pretreatment of Wistar rats with the aqueous extract of the roots of Asparagus racemosus prevented the incidence of hepatocarcinogenesis. Immunohistochemical staining of the hepatic tissues of rats treated with DEN showed the presence of p53+ foci (clusters of cells expressing the mutated p53 protein), whereas an absence of p53+ foci was observed in Wistar rats pretreated with the aqueous extract of the roots of Asparagus racemosus. The microsections of the hepatic tissue of rats treated with DEN followed by treatment with the aqueous extract of Asparagus racemosus showed an absence of p53+ foci. The results of the biochemical determinations also show that pretreatment of Wistar rats with the aqueous extract of Asparagus racemosus leads to the amelioration of oxidative stress and hepatotoxicity brought about by treatment with DEN. These results prove that the aqueous extract of the roots of Asparagus racemosus has the potential to act as an effective formulation to prevent hepatocarcinogenesis induced by treatment with DEN. Copyright (c) 2008 John Wiley & Sons, Ltd.
引用
收藏
页码:1175 / 1182
页数:8
相关论文
共 34 条
[1]   Membrane-related effects underlying the biological activity of the anthraquinones emodin and barbaloin [J].
Alves, DS ;
Pérez-Fons, L ;
Estepa, A ;
Micol, V .
BIOCHEMICAL PHARMACOLOGY, 2004, 68 (03) :549-561
[2]  
[Anonymous], AM J CLIN PATHOL
[3]   The role of p53 in tumour suppression: lessons from mouse models [J].
Attardi, LD ;
Jacks, T .
CELLULAR AND MOLECULAR LIFE SCIENCES, 1999, 55 (01) :48-63
[4]   DIFFERENTIAL SUSCEPTIBILITY OF IMMATURE RAT TESTES TO DOXORUBICIN AT CRITICAL STAGES OF MATURATION - BIOCHEMICAL AND FUNCTIONAL ASSESSMENT [J].
BECHTER, R ;
HAEBLER, R ;
ETTLIN, RA ;
HASEMAN, JK ;
DIXON, RL .
ARCHIVES OF TOXICOLOGY, 1987, 60 (06) :415-421
[5]  
Bergmeyer H.U., 1974, METHOD ENZYMAT AN, P735
[6]  
CARLBERG I, 1975, J BIOL CHEM, V250, P5475
[7]  
CODDE JP, 1990, ANTICANCER RES, V10, P1715
[8]   MEASUREMENT OF CATALASE ACTIVITY IN TISSUE EXTRACTS [J].
COHEN, G ;
DEMBIEC, D ;
MARCUS, J .
ANALYTICAL BIOCHEMISTRY, 1970, 34 (01) :30-+
[9]   Current status of Ayurveda in phytomedicine [J].
Dahanukar, SA ;
Thatte, UM .
PHYTOMEDICINE, 1997, 4 (04) :359-368
[10]  
DANIEL MK, 2006, ANN HEPATOL, V5, P16